Prosecution Insights
Last updated: August 18, 2026

Examiner: HOFFMAN, SUSAN COE

Tech Center 2100 • Art Units: 1655 1699 2178

This examiner grants 54% of resolved cases

Performance Statistics

54.2%
Allow Rate
-0.8% vs TC avg
1,154
Total Applications
+25.6%
Interview Lift
1079
Avg Prosecution Days
Based on 1078 resolved cases, 2023–2026

Rejection Statute Breakdown

10.4%
§101 Eligibility
15.1%
§102 Novelty
35.6%
§103 Obviousness
27.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18569614 MONK FRUIT EXTRACT AND METHOD FOR PRODUCING SAME Non-Final OA DAICEL CORPORATION
18703803 PRODUCTS TO TREAT AND/OR PREVENT MENSTRUAL SYMPTOMS Non-Final OA SOCIETE DES PRODUITS NESTLE S.A.
18294358 POSTBIOTIC Non-Final OA SOCIETE DES PRODUITS NESTLE S.A.
18757797 SENOTHERAPY COMPOSITION CONTAINING CAMELLIA SINENSIS EXTRACT Non-Final OA AMOREPACIFIC CORPORATION
17619014 EUTECTIC EXTRACTION OF SOLIDS Final Rejection Givaudan SA
18578588 COMPOSITION FOR INDUCING AUTOPHAGY Non-Final OA MEIJI CO., LTD.
18239287 COMPOSITION OF BOTANICAL EXTRACTS FOR SLEEP AND MOOD SUPPORT Non-Final OA NuLiv Science USA, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month